JPRN-UMIN000040132已完成未知
Effect of subsequence treatment after romosozumab in patietns with osteoporosis: open-label, randomised contorlled trial - Effect of subsequence treatment after romosozumab in patietns with osteoporosis: open-label, randomised contorlled trial
Department of Orthopaedic Surgery, Showa University School of Medicine0 个研究点目标入组 105 人开始时间: 2020年4月11日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 105
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Those who have history of cancer. 2.Patients with severe renal dysfunction or those receiving dialysis 3. Those who have hypocalcemia 4.Patients who is going to have an operation. 5.Patients who the research director judge inappropriate as a subject 6.For pregnant women or women who are nursing 7. Nonambulatory patients.
研究者
相似试验
尚未招募
Unknown
The Effects of Short-Term Romosozumab Treatment on Hip StrengthPatients with osteoporosisJPRN-UMIN000052357Showa University30
招募中
2 期
Efficacy of romosozumab and post-alendronate therapy on osteogenesis imperfectaosteogenesis imperfecta with concurrent osteoporosisD010013osteogenesis imperfectaJPRN-jRCTs031220726Ito Nobuaki20
招募中
1 期
The OPTIMIST studyosteoporosisCTIS2023-505940-20-00Region Midtjylland270
招募中
1 期
Efficacy of a sequential treatment strategy in Rheumatoid Arthritis.Rheumatoid ArthritisCTIS2022-500234-29-00niversity Hospital Montpellier220
已完成
不适用
The efficacy of re-challenge of denosumab in postmenopausal women with hormone receptor-positive breast cancer who are currently on or will iniate an aromatase inhibitor in the adjuvant settingbreast cancerJPRN-UMIN000030328Kyoto Prefectural University of medicine10